{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:21:40Z","timestamp":1792668100126,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T00:00:00Z","timestamp":1273795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12012-010-9074-y","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T16:51:40Z","timestamp":1273769500000},"page":"161-165","source":"Crossref","is-referenced-by-count":35,"title":["Comparison of the Effects of Methadone and Heroin on Human ether-\u00e0-go-go-Related Gene Channels"],"prefix":"10.1007","volume":"10","author":[{"given":"Bernd J.","family":"Z\u00fcnkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wos-Maganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,14]]},"reference":[{"key":"9074_CR1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1126\/science.272.5262.681","volume":"272","author":"MT Keating","year":"1996","unstructured":"Keating, M. T., & Sanguinetti, M. C. (1996). Molecular genetic insights into cardiovascular disease. Science, 272, 681\u2013685.","journal-title":"Science"},{"key":"9074_CR2","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1073\/pnas.91.8.3438","volume":"91","author":"JW Warmke","year":"1994","unstructured":"Warmke, J. W., & Ganetzky, B. (1994). A family of potassium channel genes related to eag in Drosophila and mammals. Proceedings of the National Academy of Sciences of the United States of America, 91, 3438\u20133442.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9074_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","volume":"81","author":"MC Sanguinetti","year":"1995","unstructured":"Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia. Cell, 81, 299\u2013307.","journal-title":"Cell"},{"key":"9074_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","volume":"269","author":"MC Trudeau","year":"1995","unstructured":"Trudeau, M. C., Warmke, J. W., Ganetzky, B., & Robertson, G. A. (1995). hERG, a human inward rectifier in the voltage-gated potassium channel family. Science, 269, 92\u201395.","journal-title":"Science"},{"key":"9074_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/med.20019","volume":"25","author":"M Recanatini","year":"2005","unstructured":"Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005). QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development. Medicinal Research Reviews, 25, 133\u2013166.","journal-title":"Medicinal Research Reviews"},{"key":"9074_CR6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","volume":"58","author":"WS Redfern","year":"2003","unstructured":"Redfern, W. S., Carlsson, L., Davis, A. S., Lynch, W. G., MacKenzie, I., Palethorpe, S., et al. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovascular Research, 58, 32\u201345.","journal-title":"Cardiovascular Research"},{"key":"9074_CR7","unstructured":"International conference on harmonization S7B guideline (CPMP\/ICH\/423\/02; 2005). The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. http:\/\/www.emea.europa.eu\/pdfs\/human\/ich\/042302en.pdf."},{"key":"9074_CR8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","volume":"303","author":"AN Katchman","year":"2002","unstructured":"Katchman, A. N., McGroary, K. A., Kilborn, M. J., Kornick, C. A., Manfredi, P. L., Woosley, R. L., et al. (2002). Influence of opioid agonists on cardiac human ether-a-go-go-related gene K+ currents. Journal of Pharmacology and Experimental Therapeutics, 303, 688\u2013694.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9074_CR9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","volume":"81","author":"CB Eap","year":"2007","unstructured":"Eap, C. B., Crettol, S., Rougier, J.-S., Schl\u00e4pfer, J., Sintra Grilo, L., Deglon, J.-J., et al. (2007). Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clinical Pharmacology and Therapeutics, 81, 719\u2013728.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"9074_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","volume":"150","author":"MJ Krantz","year":"2009","unstructured":"Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. P. (2009). QTc interval screening in methadone treatment. Annals of Internal Medicine, 150, 387\u2013395.","journal-title":"Annals of Internal Medicine"},{"key":"9074_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000167043","volume":"113","author":"C Lin","year":"2009","unstructured":"Lin, C., Somberg, T., Molnar, J., & Somberg, J. (2009). The effects of chiral isolates of methadone on the cardiac potassium channel IKr. Cardiology, 113, 59\u201365.","journal-title":"Cardiology"},{"key":"9074_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00656997","volume":"391","author":"OP Hamill","year":"1981","unstructured":"Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981). Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pfluegers Archiv, 391, 85\u2013100.","journal-title":"Pfluegers Archiv"},{"key":"9074_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00194951","volume":"48","author":"JW Vos de","year":"1995","unstructured":"de Vos, J. W., Geerlings, P. J., van den Brink, W., Ufkes, J. G., & van Wilgenburg, H. (1995). Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. European Journal of Clinical Pharmacology, 48, 361\u2013366.","journal-title":"European Journal of Clinical Pharmacology"},{"key":"9074_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/clpt.1981.34","volume":"29","author":"MK Romach","year":"1981","unstructured":"Romach, M. K., Piafsky, K. M., Abel, J. G., Khouw, V., & Sellers, E. M. (1981). Methadone binding to orosomucoid (alpha 1-acid glycoprotein): Determinant of free fraction in plasma. Clinical Pharmacology and Therapeutics, 29, 211\u2013217.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"9074_CR15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.1987.47","volume":"41","author":"CE Inturrisi","year":"1987","unstructured":"Inturrisi, C. E., Colburn, W. A., Kaiko, R. F., Houde, R. W., & Foley, K. M. (1987). Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clinical Pharmacology and Therapeutics, 41, 392\u2013401.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"9074_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clpt.2004.03.007","volume":"76","author":"M Benmebarek","year":"2004","unstructured":"Benmebarek, M., Devaud, C., Gex-Fabry, M., Powell Golay, K., Brogli, C., Baumann, P., et al. (2004). Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone. Clinical Pharmacology and Therapeutics, 76, 55\u201363.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"9074_CR17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003088-200645040-00005","volume":"45","author":"EJ Rook","year":"2006","unstructured":"Rook, E. J., Huitema, A. D. R., van den Brink, W., van Ree, J. M., & Beijnen, J. H. (2006). Population pharmacokinetics of heroin and its major metabolites. Clinical Pharmacokinetics, 45, 401\u2013417.","journal-title":"Clinical Pharmacokinetics"},{"key":"9074_CR18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3181\/00379727-147-38411","volume":"147","author":"GL Cohn","year":"1974","unstructured":"Cohn, G. L., Cramer, J. A., McBride, W., Brown, R. C., & Kleber, H. D. (1974). Heroin and morphine binding with human serum proteins and red blood cells. Proceedings of the Society for Experimental Biology and Medicine, 147, 664\u2013666.","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"9074_CR19","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","volume":"97","author":"JS Mitcheson","year":"2000","unstructured":"Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000). A structural basis for drug-induced long QT syndrome. Proceedings of the National Academy of Sciences of the United States of America, 97, 12329\u201312333.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9074_CR20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2005.01.003","volume":"26","author":"MC Sanguinetti","year":"2005","unstructured":"Sanguinetti, M. C., & Mitcheson, J. S. (2005). Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends in Pharmacological Sciences, 26, 119\u2013124.","journal-title":"Trends in Pharmacological Sciences"},{"key":"9074_CR21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2006.03.002","volume":"112","author":"BJ Z\u00fcnkler","year":"2006","unstructured":"Z\u00fcnkler, B. J. (2006). Human ether-a-go-go-related (hERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects. Pharmacology and Therapeutics, 112, 12\u201337.","journal-title":"Pharmacology and Therapeutics"},{"key":"9074_CR22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.bjp.0705335","volume":"139","author":"JT Milnes","year":"2003","unstructured":"Milnes, J. T., Crociani, O., Arcangeli, A., Hancox, J. C., & Witchel, H. J. (2003). Blockade of hERG potassium currents by fluvoxamine: Incomplete attenuation by S6 mutations at F656 or Y652. British Journal of Pharmacology, 139, 887\u2013898.","journal-title":"British Journal of Pharmacology"},{"key":"9074_CR23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjp.0705336","volume":"139","author":"JS Mitcheson","year":"2003","unstructured":"Mitcheson, J. S. (2003). Drug binding to hERG channels: Evidence for a \u201cnon-aromatic\u201d binding site for fluvoxamine. British Journal of Pharmacology, 139, 883\u2013884.","journal-title":"British Journal of Pharmacology"},{"key":"9074_CR24","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/sj.bjp.0707356","volume":"151","author":"D Stork","year":"2007","unstructured":"Stork, D., Timin, E. N., Berjukow, S., Huber, C., Hohaus, A., Auer, M., et al. (2007). State dependent dissociation of hERG channel inhibitors. British Journal of Pharmacology, 151, 1368\u20131376.","journal-title":"British Journal of Pharmacology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-010-9074-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-010-9074-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-010-9074-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:40:20Z","timestamp":1559439620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-010-9074-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,14]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9074"],"URL":"https:\/\/doi.org\/10.1007\/s12012-010-9074-y","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,14]]}}}